FTSE All-Share
4.661,70
PKT
+51,16
PKT
+1,11
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.05.24 | Diageo Underperform | RBC Capital Markets | |
| 03.05.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 03.05.24 | GSK Halten | DZ BANK | |
| 03.05.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 03.05.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Kaufen | DZ BANK | |
| 02.05.24 | Glencore Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | HSBC Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | GSK Buy | Deutsche Bank AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.05.24 | HSBC Neutral | UBS AG | |
| 02.05.24 | GSK Buy | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 02.05.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 02.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 01.05.24 | BP Outperform | RBC Capital Markets | |
| 01.05.24 | GSK Buy | UBS AG | |
| 01.05.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 01.05.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.24 | HSBC Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.24 | Unilever Halten | DZ BANK | |
| 30.04.24 | Glencore Equal Weight | Barclays Capital | |
| 30.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.04.24 | HSBC Neutral | JP Morgan Chase & Co. | |
| 30.04.24 | HSBC Neutral | UBS AG | |
| 30.04.24 | HSBC Buy | Jefferies & Company Inc. | |
| 30.04.24 | HSBC Sector Perform | RBC Capital Markets | |
| 30.04.24 | HSBC Buy | Goldman Sachs Group Inc. | |
| 29.04.24 | National Grid Outperform | RBC Capital Markets | |
| 29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.04.24 | Diageo Sell | UBS AG | |
| 29.04.24 | GSK Buy | UBS AG | |
| 29.04.24 | Unilever Overweight | Barclays Capital | |
| 26.04.24 | AstraZeneca Halten | DZ BANK | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 26.04.24 | Unilever Sell | UBS AG | |
| 26.04.24 | AstraZeneca Hold | Deutsche Bank AG |